Related Experiment Video

Updated: Jun 18, 2026

The MUB40 Peptide for Use in Detecting Neutrophil-Mediated Inflammation Events
06:48

The MUB40 Peptide for Use in Detecting Neutrophil-Mediated Inflammation Events

Published on: January 7, 2019

6.5K

A paradigm shift in neutrophil adverse event grading: Why now?

Lauren E Merz1

  • 1Department of Medicine Division of Hematology/Oncology University of Michigan Ann Arbor Michigan United States.

Hemasphere
|October 29, 2025
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli14:05

Morphological and Compositional Analysis of Neutrophil Extracellular Traps Induced by Microbial and Chemical Stimuli

Published on: November 4, 2022

3.0K
Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists11:32

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists

Published on: October 18, 2024

1.1K

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).